Page 29 - Global Tracker News Today

CDC Panel Talk Ends Without Vote; Pfizer Boost: Virus Update Bloomberg 2 days ago Bloomberg News © Photographer: Eva Marie Uzcategui/Bloomberg A U.S. Army soldier prepares to administer Johnson & Johnson Janssen Covid-19 vaccines at a vaccination center at the Miami Dade College North Campus in North Miami, Florida. (Bloomberg) -- A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote. Pfizer Inc. and BioNT...

CDC Panel Mulls Monthlong J&J Pause; Pfizer Boost: Virus Update Bloomberg 37 mins ago Bloomberg News © Photographer: Eva Marie Uzcategui/Bloomberg A U.S. Army soldier prepares to administer Johnson & Johnson Janssen Covid-19 vaccines at a vaccination center at the Miami Dade College North Campus in North Miami, Florida. (Bloomberg) -- A Centers for Disease Control and Prevention panel is considering a monthlong pause in the distribution of Johnson & Johnson’s vaccine. Pfi...

India Has 2nd-Most Cases; U.K. Hits Vaccine Target: Virus Update Bloomberg 2 hrs ago Bloomberg News (Bloomberg) -- India overtook Brazil as the country with the second-most cases in the world. A study in Brazil showed that Sinovac Biotech Ltd.’s vaccine is slightly more than 50% effective, raising new concerns over the efficacy of the China’s suite of Covid-19 shots. The U.K. hit its goal of offering a shot to all those over 50 three days early. England reopened shops, pub...

India Has 2nd-Most Cases; Indonesia Keeps Sinovac: Virus Update Bloomberg 59 mins ago Bloomberg News (Bloomberg) -- India overtook Brazil as the country with the second-most cases in the world. Indonesia is sticking with Sinovac Biotech Ltd.’s vaccine even as a study raised new concerns over the efficacy of the China’s suite of Covid-19 shots. Italy is in talks to set up vaccine production hubs as the government seeks to build up domestic capacity amid concern the country ...

U.S. health officials recommended a pause in the use of Johnson & Johnson’s vaccine on concerns about rare and severe blood-clotting side effects.

The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.

U.S. health officials recommended a pause in the use of Johnson & Johnson’s vaccine on concerns about rare and severe blood-clotting side effects.

The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.

India overtook Brazil as the country with the second-most cases in the world. Indonesia is sticking with Sinovac Biotech Ltd.’s vaccine even as a study raised new concerns over the efficacy of the China’s suite of Covid-19 shots.

France Halts Brazil Flights; NYC Reschedules Shots: Virus Update Bloomberg 17 mins ago Bloomberg News (Bloomberg) -- The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe. German Chancellor Angela Merkel’s cabinet approved a law setting nationwide rules on virus restrictions after some regions failed to...